Isopropylphenidate Production Cost Reports

The report provides a detailed analysis essential for establishing an Isopropylphenidate production plant. It encompasses all critical aspects necessary for Isopropylphenidate production, including the cost of Isopropylphenidate production, Isopropylphenidate plant cost, Isopropylphenidate production costs, and the overall Isopropylphenidate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Isopropylphenidate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Isopropylphenidate is a stimulant drug closely related to methylphenidate, synthesised as an isopropyl ester of ritalinic acid. It is primarily utilised as a potential therapeutic agent for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy, offering similar stimulant effects but with a longer duration of action and a potentially improved safety profile due to reduced norepinephrine reuptake inhibition.

Additionally, compared to methylphenidate, isopropylphenidate has greater resistance to metabolic breakdown and a stronger dopaminergic effect, which may result in more sustained stimulation and fewer cardiovascular side effects. Its pharmacological profile supports its development as a novel CNS stimulant with applications in neurobehavioral disorder treatment, although it has also appeared as a designer drug in unregulated markets.

The market drivers for isopropylphenidate depend on its growing utilisation as a cognitive enhancer and a potential alternative treatment for attention-deficit hyperactivity disorder (ADHD). Its structural similarity to methylphenidate, combined with benefits such as a longer duration of action, fewer side effects, and greater metabolic stability, makes it appealing for pharmaceutical development and consumer use. Additionally, increasing demand for nootropics and smart drugs in competitive academic and professional environments also fuels market interest. Advances in scientific research exploring its effects on focus, attention, and wakefulness contribute to market growth, alongside expanding use in neurobehavioral disorder treatment.

However, regulatory scrutiny of novel psychoactive substances and evolving legal frameworks require manufacturers and stakeholders to carefully navigate compliance while validating safety and efficacy, which impacts industrial isopropylphenidate procurement. The availability and cost of high-purity raw materials such as ritalinic acid and isopropyl alcohol, along with consistent supply chain reliability for catalyst gases like hydrogen chloride, also influence the procurement. Furthermore, production complexity, including the need for specialised equipment for esterification and purification steps, also impacts procurement decisions.

Raw Material for Isopropylphenidate Production

According to the Isopropylphenidate production plant project report, the various raw materials for Isopropylphenidate production include Ritalinic acid- isopropyl alcohol.

Production Process of Isopropylphenidate

The extensive Isopropylphenidate production cost report consists of the following major industrial production process:

• Production via esterification reaction: The production process of isopropylphenidate involves the esterification of (±)-ritalinic acid (RA) with isopropyl alcohol. The reaction is performed under acidic conditions with hydrogen chloride (HCl) gas serving as the catalyst. In the process, RA (2 mM) is dissolved in isopropyl alcohol saturated with HCl gas and refluxed for 24 hours under a nitrogen atmosphere at around 80 degree Celsius. After completion, the reaction mixture is evaporated to dryness, leaving a white crystalline product that is purified by recrystallisation, using diethyl ether to produce isopropylphenidate.

Properties of Isopropylphenidate

Isopropylphenidate is a white crystalline solid with the molecular formula C16H23NO2 for the free base and C16H24ClNO2 for its hydrochloride salt, which has a molecular weight of 297.82 g/mol. It contains a phenyl ring, a piperidine ring in a chair conformation, and an isopropyl ester group. The compound has two stereocentres leading to multiple stereoisomers, with the pharmacologically relevant form being the racemic threo isomer. Its hydrochloride form exhibits improved water solubility and stability compared to the free base. The compound is handled as a stable, non-flammable solid under standard laboratory conditions, showing a characteristic odour common to nitrogen-containing organics.